H1 Blog

OCTOBER 16, 2023

AI can help in speeding up various phases like target identification, molecule optimization, and pre-clinical testing, thereby reducing the cost and time to bring a drug to market. Faster Time-to-Market: AI-driven predictive maintenance can reduce machine downtime, ensuring smoother manufacturing processes and quicker product delivery.

Science 59

Science Clinical Trials Trials Therapies 59

H1 Blog

JULY 24, 2023

Strategies for Market Access Teams One thing the healthcare ecosystem lacks in the United States is a system of shareable, actionable healthcare data. Understanding which treatments are being utilized, by whom, and for what length of time can help inform pharmaceutical operations on how best to meet patient needs.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Pharmacy 52

H1 Blog

MARCH 28, 2023

In fact, the global medical devices market is projected to grow from $495.46 Understanding and incorporating the payer perspective and data requirements early in product development is essential in this increasingly cost-conscious market. To learn more about Carevoyance, H1’s Claims Intelligence Solution, request a demo.

Production 52

Production Marketing Treatment Hospitals 52

H1 Blog

DECEMBER 18, 2023

DOLs will also increasingly turn back to in-person interactions, conferences, public speaking, and other direct means to voice their opinions and establish a more credible presence, moving away from digital platforms.” – Alexandra Moens, Senior Director of Product Marketing 4.

Trials 64

Trials Clinical Trials FDA Pharmaceutical Companies 64

H1 Blog

JULY 5, 2023

From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. To learn more about how H1 can help diversify your HCP engagement strategy, request a demo.

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

H1 Blog

SEPTEMBER 26, 2023

When it comes to developing new treatments and vaccines, the development timeline is often long and arduous, especially outside of the U.S. Ukraine and many neighboring countries were and still are relying on these clinical trials to bring new and improved medicine, treatments and technology to healthcare.

Trials 59

Trials Clinical Trials International Regulations 59

H1 Blog

JUNE 7, 2023

Performance data on past trials can help identify patient groups that tend to respond better to certain treatments, recommend specific principal investigators based on their track record in similar trials, and even suggest optimal trial sites based on historical performance. The Michael J.

Trials 52

Trials Clinical Trials Pharma Companies Clinical Development 52